The Rivertown Therapeutics, Inc. patent portfolio has been written and prosecuted by Steven Weinstock, Esq. Mr. Weinstock worked at Abbott Pharmaceuticals for 20 years, were he served as Chief Patent Counsel. Ours is an active, worldwide patent strategy that is intended to both protect our intellectual property and to anticipate and preclude our competitors from entry into the field. In addition to patent coverage around our lead compounds and indications we have crafted a patent straegy that covers both dermatologic and non-dermatologic indications for these suites of drug substances. We anticipate this will allow for generation of additional drugs for related indications, while blocking competitor entry into the field.